|Tumor protein 53-induced nuclear protein 1 expression is repressed by miR-155, and its restoration inhibits pancreatic tumor development|
M Gironella, M Seux, MJ Xie, C Cano, R Tomasini, J Gommeaux, S Garcia, ...
Proceedings of the National Academy of Sciences 104 (41), 16170-16175, 2007
|Intraprostatic androgens and androgen-regulated gene expression persist after testosterone suppression: therapeutic implications for castration-resistant prostate cancer|
EA Mostaghel, ST Page, DW Lin, L Fazli, IM Coleman, LD True, ...
Cancer research 67 (10), 5033-5041, 2007
|The androgen receptor fuels prostate cancer by regulating central metabolism and biosynthesis|
CE Massie, A Lynch, A Ramos‐Montoya, J Boren, R Stark, L Fazli, ...
The EMBO journal 30 (13), 2719-2733, 2011
|Heat shock protein 27 increases after androgen ablation and plays a cytoprotective role in hormone-refractory prostate cancer|
P Rocchi, A So, S Kojima, M Signaevsky, E Beraldi, L Fazli, ...
Cancer research 64 (18), 6595-6602, 2004
|Monoclonal antibody targeting of N-cadherin inhibits prostate cancer growth, metastasis and castration resistance|
H Tanaka, E Kono, CP Tran, H Miyazaki, J Yamashiro, T Shimomura, ...
Nature medicine 16 (12), 1414-1420, 2010
|Regulation of tumor angiogenesis by integrin-linked kinase (ILK)|
C Tan, S Cruet-Hennequart, A Troussard, L Fazli, P Costello, K Sutton, ...
Cancer cell 5 (1), 79-90, 2004
|A phase I pharmacokinetic and pharmacodynamic study of OGX-011, a 2′-methoxyethyl antisense oligonucleotide to clusterin, in patients with localized prostate cancer|
KN Chi, E Eisenhauer, L Fazli, EC Jones, SL Goldenberg, J Powers, D Tu, ...
Journal of the National Cancer Institute 97 (17), 1287-1296, 2005
|Cooperative interactions between androgen receptor (AR) and heat-shock protein 27 facilitate AR transcriptional activity|
A Zoubeidi, A Zardan, E Beraldi, L Fazli, R Sowery, P Rennie, C Nelson, ...
Cancer research 67 (21), 10455-10465, 2007
|High fidelity patient-derived xenografts for accelerating prostate cancer discovery and drug development|
D Lin, AW Wyatt, H Xue, Y Wang, X Dong, A Haegert, R Wu, S Brahmbhatt, ...
Cancer research 74 (4), 1272-1283, 2014
|Increased Hsp27 after androgen ablation facilitates androgen-independent progression in prostate cancer via signal transducers and activators of transcription 3–mediated …|
P Rocchi, E Beraldi, S Ettinger, L Fazli, RL Vessella, C Nelson, M Gleave
Cancer research 65 (23), 11083-11093, 2005
|Targeting ASCT2‐mediated glutamine uptake blocks prostate cancer growth and tumour development|
Q Wang, RA Hardie, AJ Hoy, M Van Geldermalsen, D Gao, L Fazli, ...
The Journal of pathology 236 (3), 278-289, 2015
|Frequency of the TMPRSS2: ERG gene fusion is increased in moderate to poorly differentiated prostate cancers|
AB Rajput, MA Miller, A De Luca, N Boyd, S Leung, A Hurtado-Coll, ...
Journal of clinical pathology 60 (11), 1238-1243, 2007
|Insulin receptor expression by human prostate cancers|
ME Cox, ME Gleave, M Zakikhani, RH Bell, E Piura, E Vickers, ...
The Prostate 69 (1), 33-40, 2009
|The 44-kDa Pim-1 kinase phosphorylates BCRP/ABCG2 and thereby promotes its multimerization and drug-resistant activity in human prostate cancer cells|
Y Xie, K Xu, DE Linn, X Yang, Z Guo, H Shimelis, T Nakanishi, DD Ross, ...
Journal of Biological Chemistry 283 (6), 3349-3356, 2008
|Increased insulin-like growth factor I receptor expression and signaling are components of androgen-independent progression in a lineage-derived prostate cancer progression model|
SL Krueckl, RA Sikes, NM Edlund, RH Bell, A Hurtado-Coll, L Fazli, ...
Cancer research 64 (23), 8620-8629, 2004
|Nucleotide-based therapies targeting clusterin chemosensitize human lung adenocarcinoma cells both in vitro and in vivo|
LV July, E Beraldi, A So, L Fazli, K Evans, JC English, ME Gleave
Molecular cancer therapeutics 3 (3), 223-232, 2004
|Hsp27 regulates epithelial mesenchymal transition, metastasis, and circulating tumor cells in prostate cancer|
M Shiota, JL Bishop, KM Nip, A Zardan, A Takeuchi, T Cordonnier, ...
Cancer research 73 (10), 3109-3119, 2013
|Association of TMPRSS2-ERG gene fusion with clinical characteristics and outcomes: results from a population-based study of prostate cancer|
LM FitzGerald, I Agalliu, K Johnson, MA Miller, EM Kwon, A Hurtado-Coll, ...
BMC cancer 8 (1), 1-10, 2008
|From sequence to molecular pathology, and a mechanism driving the neuroendocrine phenotype in prostate cancer|
AV Lapuk, C Wu, AW Wyatt, A McPherson, BJ McConeghy, S Brahmbhatt, ...
The Journal of pathology 227 (3), 286-297, 2012
|The placental gene PEG10 promotes progression of neuroendocrine prostate cancer|
S Akamatsu, AW Wyatt, D Lin, S Lysakowski, F Zhang, S Kim, C Tse, ...
Cell reports 12 (6), 922-936, 2015